Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • plabaj
    Member
    • Oct 2010
    • 95

    #1

    Oxford Nanopore ‘Wiggle Space’ Challenge

    Dear Colleagues,

    The Call for Contributions to CAMDA @ISMB/ECCB is now open!

    Several gut microbiota samples had their DNA sequenced both by Nanopore long read next-next-generation sequencing as well as more established Illumina sequencing technology (Mason lab, New York, original unpublished data). Additional ‘mystery’ samples provide an independent blind test.

    Questions of interest include, but are not limited to
    • Technical: Improve base-calling, assembly, and signal level models of the Nanopore data with the reference sequences and/or Illumina sequencing serving as benchmark. We have samples with biological and samples with technical replicates.
    • Biological: Meta-genomics: Detection, discrimination, and abundance quantification of species. For some training samples, relative abundances are known (synthetic mixes). Sequence / functional predictive analysis of pathogenicity. And: Analysis and identification of the ‘mystery’ sample!


    Check also other CAMDA challenges!

    Join us for a stimulating scientific meeting and lively discussions in Prague 22-23 July 2017!

    Follow us on twitter @CAMDA_conf

    See you in Prague!
    Pawel Labaj
  • ymc
    Senior Member
    • Mar 2010
    • 496

    #2
    Interesting. So the idea is to use your data and submit paper to the conference?

    Comment

    • plabaj
      Member
      • Oct 2010
      • 95

      #3
      Camda

      Yes!

      There are in fact two Submission Options:
      1. Full methods research papers can be submitted to the regular ISMB Proceedings Track (note 26th of January ISMB Proceedings deadline!), specifying CAMDA as intended target audience.
      2. Extended abstracts of late breaking methods research or analyses of the CAMDA challenge data sets can be submitted by the CAMDA submission deadline in May. Extended abstracts should include at least preliminary key results and figures. Based on the extended abstract, the scientific committee selects teams to present their work at the CAMDA conference, where updated results need to be shown.
      Pawel Labaj

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      22 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      39 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Working...